Online Exclusive Articles

Dr Steinhaus is an electrophysiologist at Saint Luke’s Health System, and Dr Fendler is a heart failure cardiologist at Saint Luke’s Mid America Heart Institute and assistant professor at the University of Missouri–Kansas City.

Sandeep Goyal, MD, discusses how Piedmont Healthcare has integrated 2 key technologies shaping the future of AF treatment: the Affera™ mapping and ablation system and PulseSelect™ PFA system (Medtronic).

James Freeman, MD, MPH, MS, Professor of Medicine at the Yale School of Medicine, Director of the Cardiac Electrophysiology Laboratories for Yale New Haven Health, and Director of the Yale Atrial Fibrillation (AFib) Program, discusses his...

Lama Al Jebbawi, MD, discusses this upcoming roundtable at the 2026 Western Atrial Fibrillation (AFib) Symposium.

Jason Chinitz, MD discusses the central role of ICE in advancing procedural safety, efficiency, and operator control—spanning fluoroless AF ablation, LAAO, and concomitant procedures.

Frank Cuoco, MD, MBA, MS, co-director of Cardiac Electrophysiology and the Director of Cardiovascular Outreach for HCA Trident Health, discusses his upcoming roundtable at Western AFib 2026.

In this interview, Emma Svennberg, MD, PhD, discusses the evolving evidence behind early rhythm control, the growing importance of AF burden, and how RFM and smarter screening pathways may shift the trajectory of the disease.

EP Lab Digest speaks with Dr. Andrew M. Goldsweig, coauthor of the Society for Cardiovascular Angiography & Interventions (SCAI) Position Statement on ICE to Guide Structural Heart Disease Interventions.